News & Articles

Results per page

25

Articles Filter

Field

See more

Technique

Browse by Techniques

Company

Explore by Company

Type of Content




Editorial ArticleLife Sciences

What next for CRISPR after first therapeutic approvals?

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality